- Home
- ASGN vs VCEL Comparison
ASGN vs VCEL Comparison
Compare ASGN & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASGN
- VCEL
- Stock Information
- Founded
- ASGN 1985
- VCEL 1989
- Country
- ASGN United States
- VCEL United States
- Employees
- ASGN N/A
- VCEL N/A
- Industry
- ASGN Professional Services
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ASGN Consumer Discretionary
- VCEL Health Care
- Exchange
- ASGN Nasdaq
- VCEL Nasdaq
- Market Cap
- ASGN 2.3B
- VCEL 2.1B
- IPO Year
- ASGN 1992
- VCEL 1997
- Fundamental
- Price
- ASGN $52.82
- VCEL $41.30
- Analyst Decision
- ASGN Hold
- VCEL Strong Buy
- Analyst Count
- ASGN 5
- VCEL 8
- Target Price
- ASGN $74.40
- VCEL $62.00
- AVG Volume (30 Days)
- ASGN 472.0K
- VCEL 583.6K
- Earning Date
- ASGN 07-23-2025
- VCEL 05-08-2025
- Dividend Yield
- ASGN N/A
- VCEL N/A
- EPS Growth
- ASGN N/A
- VCEL 521.85
- EPS
- ASGN 3.52
- VCEL 0.05
- Revenue
- ASGN $4,019,000,000.00
- VCEL $238,541,000.00
- Revenue This Year
- ASGN N/A
- VCEL $23.03
- Revenue Next Year
- ASGN $3.30
- VCEL $24.52
- P/E Ratio
- ASGN $15.02
- VCEL $698.09
- Revenue Growth
- ASGN N/A
- VCEL 14.80
- 52 Week Low
- ASGN $47.64
- VCEL $37.39
- 52 Week High
- ASGN $105.67
- VCEL $63.00
- Technical
- Relative Strength Index (RSI)
- ASGN 40.86
- VCEL 48.12
- Support Level
- ASGN $52.89
- VCEL $40.38
- Resistance Level
- ASGN $55.40
- VCEL $42.57
- Average True Range (ATR)
- ASGN 1.44
- VCEL 1.69
- MACD
- ASGN -0.02
- VCEL 0.06
- Stochastic Oscillator
- ASGN 11.42
- VCEL 22.90
About ASGN ASGN Incorporated
ASGN Inc is a provider of information technology (IT) services and professional solutions, including technology, creative, and digital, across the commercial and government sectors. It operates through two segments, Commercial and Federal Government. The Commercial Segment, which generates the majority of the revenue, provides consulting, creative digital marketing, and permanent placement services to Fortune 1000 clients and mid-market companies. The Federal Government Segment provides mission-critical solutions to the Department of Defense, intelligence agencies, and civilian agencies.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.